1. Home
  2. CTRI vs BHVN Comparison

CTRI vs BHVN Comparison

Compare CTRI & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centuri Holdings Inc.

CTRI

Centuri Holdings Inc.

N/A

Current Price

$20.54

Market Cap

2.4B

Sector

N/A

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$15.69

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTRI
BHVN
Founded
1909
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.3B
IPO Year
2024
2022

Fundamental Metrics

Financial Performance
Metric
CTRI
BHVN
Price
$20.54
$15.69
Analyst Decision
Hold
Buy
Analyst Count
5
14
Target Price
$29.88
$29.08
AVG Volume (30 Days)
1.5M
2.9M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
412.50
26.08
EPS
N/A
N/A
Revenue
$2,982,781,000.00
N/A
Revenue This Year
$14.62
N/A
Revenue Next Year
$8.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.10
N/A
52 Week Low
$19.04
$7.48
52 Week High
$42.99
$18.57

Technical Indicators

Market Signals
Indicator
CTRI
BHVN
Relative Strength Index (RSI) 34.34 57.61
Support Level N/A $13.56
Resistance Level $27.72 $17.76
Average True Range (ATR) 0.73 1.28
MACD 0.04 0.14
Stochastic Oscillator 17.30 55.73

Price Performance

Historical Comparison
CTRI
BHVN

About CTRI Centuri Holdings Inc.

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. Its reportable segments are: (i) U.S. Gas Utility Services (U.S. Gas); (ii) Canadian Utility Services (Canadian Operations); (iii) Union Electric Utility Services (Union Electric); and (iv) Non-Union Electric Utility Services (Non-Union Electric).

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: